Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation

Obiettivo

Electrical brain stimulation has been successfully used since the 1990s to treat neurological illnesses, particularly movement disorders.
Most of the devices for this novel approach are based on the old pacemaker technology. Companies are unwilling to take device development risks & rely on established tech, limiting new therapy developments. Many neurological diseases are still treated with pharmaceuticals only, which has limited effectiveness and causes severe side effects. Neuromodulation—electrical stimulation research has increased in recent decades. Additional recording capabilities & closed loop therapy expand therapeutic options.
CorTec aims to provide novel implantable tech to overcome the current limitations: it enables researchers, medical institutions & industry to develop new therapies & devices. We plan to finalise the development of our tech for stroke rehabilitation, conduct clinical trials & get market approval in 2029, generating €250M in sales in 2030.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-EIC-2022-ACCELERATOR-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

CORTEC GMBH
Contributo netto dell'UE
€ 2 500 000,00
Indirizzo
NEUER MESSPLATZ 3
79108 Freiburg Im Breisgau
Germania
PMI
Sì
Regione
Baden-Württemberg Freiburg Freiburg im Breisgau, Stadtkreis
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 3 675 427,50